Abstract Introduction

Speaker(s)

• 

  Richard LeBlanc, MD (he/him/his)

  Full Professor of Medicine and Myeloma Canada Chair
  Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
  Montreal, Quebec, Canada